Gender Male
Investor Type
Bill Wickline is the is the managing director of Bridge Bank's Life Sciences Group.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Noctrix Health | Bridge Bank | Debt Financing - Noctrix Health | obfuscated obfuscation | |
obfuscated obfuscation | ![]() Catalyst OrthoScience | Bridge Bank | ![]() Venture Round - Catalyst OrthoScience | obfuscated obfuscation | |
obfuscated obfuscation | ![]() Cytosorbents | Bridge Bank | ![]() Post-IPO Debt - Cytosorbents | obfuscated obfuscation |